Ledger.Open graph →
SEC Form D · Amendment · filed January 29, 2024

CorriXR Therapeutics, Inc

Offering
$8.0M
Sold
$6.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Newark, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jon Brilliant · Irving, TXExecJeffrey Carper · Wilmington, DEDirectorDeborah Moorad · Newark, DEExec · DirectorJanice Nevin · Wilmington, DEDirectorStella Vnook · ORLANDO, FLDirectorEric Kmiec · Wilmington, DEExec · DirectorJeffrey Carper · Wilmington, DEDirectorJon Brilliant · CENTREVILLE, DEExecDeborah Moorad · Newark, DEExec · DirectorJanice Nevin · Wilmington, DEDirectorStella Vnook · Newark, DEDirectorEric Kmiec · Wilmington, DEExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗